FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2295623373> ?p ?o ?g. }

• W2295623373 endingPage "480" @default.
• W2295623373 startingPage "472" @default.
• W2295623373 abstract "The purpose of this study was to assess the feasibility and safety of transcarotid transcatheter aortic valve replacement (TAVR). Many candidates for TAVR have challenging vascular anatomy that precludes transfemoral access. Transcarotid arterial access may be an option for such patients. The French Transcarotid TAVR Registry is a voluntary database that prospectively collected patient demographics, procedural characteristics, and clinical outcomes among patients undergoing transcarotid TAVR. Outcomes are reported according to the updated Valve Academic Research Consortium criteria. Among 96 patients undergoing transcarotid TAVR at 3 French sites (2009 to 2013), the mean age and Society of Thoracic Surgeons predicted risk of mortality were 79.4 ± 9.2 years and 7.1 ± 4.1%, respectively. Successful carotid artery access was achieved in all patients. The Medtronic CoreValve (Medtronic, Inc., Minneapolis, Minnesota) (n = 89; 92.7%) and Edwards SAPIEN valves (Edwards Lifesciences, Irvine, California) (n = 7; 7.3%) were used. Procedural complications included: valve embolization (3.1%), requirement for a second valve (3.1%), and tamponade (4.2%). There were no major bleeds or major vascular complications related to the access site. There were 3 (3.1%) procedural deaths and 6 (6.3%) deaths at 30 days. The 1-year mortality rate was 16.7%. There were 3 (3.1%) cases of Valve Academic Research Consortium–defined in-hospital stroke (n = 0) or transient ischemic attack (TIA) (n = 3). None of these patients achieved the criteria for stroke and none manifested new ischemic lesions on cerebral computed tomography or magnetic resonance imaging. At 30 days, a further 3 TIAs were observed, giving an overall stroke/TIA rate of 6.3%. Transcarotid vascular access for TAVR is feasible and is associated with encouraging short- and medium-term clinical outcomes. Prospective studies are required to ascertain if transcarotid TAVR yields equivalent results to other nonfemoral vascular access routes." @default.
• W2295623373 created "2016-06-24" @default.
• W2295623373 creator A5001725935 @default.
• W2295623373 creator A5001767667 @default.
• W2295623373 creator A5004379451 @default.
• W2295623373 creator A5014743420 @default.
• W2295623373 creator A5018658386 @default.
• W2295623373 creator A5025577836 @default.
• W2295623373 creator A5026998439 @default.
• W2295623373 creator A5029428831 @default.
• W2295623373 creator A5033599517 @default.
• W2295623373 creator A5039252368 @default.
• W2295623373 creator A5054124858 @default.
• W2295623373 creator A5066344919 @default.
• W2295623373 creator A5075664480 @default.
• W2295623373 creator A5079847964 @default.
• W2295623373 date "2016-03-01" @default.
• W2295623373 modified "2023-10-18" @default.
• W2295623373 title "Transcarotid Transcatheter Aortic Valve Replacement" @default.
• W2295623373 cites W1547634900 @default.
• W2295623373 cites W189624128 @default.
• W2295623373 cites W1969661146 @default.
• W2295623373 cites W1973617689 @default.
• W2295623373 cites W1977386864 @default.
• W2295623373 cites W1984408083 @default.
• W2295623373 cites W1985947431 @default.
• W2295623373 cites W2019115124 @default.
• W2295623373 cites W2023833069 @default.
• W2295623373 cites W2036505339 @default.
• W2295623373 cites W2060346864 @default.
• W2295623373 cites W2067102144 @default.
• W2295623373 cites W2095462158 @default.
• W2295623373 cites W2102679179 @default.
• W2295623373 cites W2113479080 @default.
• W2295623373 cites W2121588050 @default.
• W2295623373 cites W2132585880 @default.
• W2295623373 cites W2149609916 @default.
• W2295623373 cites W2158490705 @default.
• W2295623373 cites W2162586165 @default.
• W2295623373 cites W2217533272 @default.
• W2295623373 cites W2698758261 @default.
• W2295623373 cites W4237799954 @default.
• W2295623373 doi "https://doi.org/10.1016/j.jcin.2015.11.045" @default.
• W2295623373 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26965937" @default.
• W2295623373 hasPublicationYear "2016" @default.
• W2295623373 type Work @default.
• W2295623373 sameAs 2295623373 @default.
• W2295623373 citedByCount "116" @default.
• W2295623373 countsByYear W22956233732016 @default.
• W2295623373 countsByYear W22956233732017 @default.
• W2295623373 countsByYear W22956233732018 @default.
• W2295623373 countsByYear W22956233732019 @default.
• W2295623373 countsByYear W22956233732020 @default.
• W2295623373 countsByYear W22956233732021 @default.
• W2295623373 countsByYear W22956233732022 @default.
• W2295623373 countsByYear W22956233732023 @default.
• W2295623373 crossrefType "journal-article" @default.
• W2295623373 hasAuthorship W2295623373A5001725935 @default.
• W2295623373 hasAuthorship W2295623373A5001767667 @default.
• W2295623373 hasAuthorship W2295623373A5004379451 @default.
• W2295623373 hasAuthorship W2295623373A5014743420 @default.
• W2295623373 hasAuthorship W2295623373A5018658386 @default.
• W2295623373 hasAuthorship W2295623373A5025577836 @default.
• W2295623373 hasAuthorship W2295623373A5026998439 @default.
• W2295623373 hasAuthorship W2295623373A5029428831 @default.
• W2295623373 hasAuthorship W2295623373A5033599517 @default.
• W2295623373 hasAuthorship W2295623373A5039252368 @default.
• W2295623373 hasAuthorship W2295623373A5054124858 @default.
• W2295623373 hasAuthorship W2295623373A5066344919 @default.
• W2295623373 hasAuthorship W2295623373A5075664480 @default.
• W2295623373 hasAuthorship W2295623373A5079847964 @default.
• W2295623373 hasConcept C126322002 @default.
• W2295623373 hasConcept C127413603 @default.
• W2295623373 hasConcept C141071460 @default.
• W2295623373 hasConcept C144024400 @default.
• W2295623373 hasConcept C149923435 @default.
• W2295623373 hasConcept C164705383 @default.
• W2295623373 hasConcept C2780007028 @default.
• W2295623373 hasConcept C2780026749 @default.
• W2295623373 hasConcept C2780084366 @default.
• W2295623373 hasConcept C2780645631 @default.
• W2295623373 hasConcept C2780714102 @default.
• W2295623373 hasConcept C71924100 @default.
• W2295623373 hasConcept C78519656 @default.
• W2295623373 hasConceptScore W2295623373C126322002 @default.
• W2295623373 hasConceptScore W2295623373C127413603 @default.
• W2295623373 hasConceptScore W2295623373C141071460 @default.
• W2295623373 hasConceptScore W2295623373C144024400 @default.
• W2295623373 hasConceptScore W2295623373C149923435 @default.
• W2295623373 hasConceptScore W2295623373C164705383 @default.
• W2295623373 hasConceptScore W2295623373C2780007028 @default.
• W2295623373 hasConceptScore W2295623373C2780026749 @default.
• W2295623373 hasConceptScore W2295623373C2780084366 @default.
• W2295623373 hasConceptScore W2295623373C2780645631 @default.
• W2295623373 hasConceptScore W2295623373C2780714102 @default.
• W2295623373 hasConceptScore W2295623373C71924100 @default.
• W2295623373 hasConceptScore W2295623373C78519656 @default.
• W2295623373 hasIssue "5" @default.

• next